Company: GMRE
Filing Date: 2025-11-14
Form Type: 424B5
Source: 0001104659-25-112543
Chunk: 48

Company: Global Medical REIT Inc.
Filing Date: 2025-11-14
Form: 424B5
Chunk 48
---
 Preferred Stock are
not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail
investor in the United Kingdom (“UK”). For these purposes, a retail investor means a person who is one (or more) of (i) a
retail client, as defined in point (11) of Article 4(1) of MiFID II as it forms part of domestic law by virtue of the European
Union (Withdrawal) Act 2018 (“EUWA”); (ii) a customer within the meaning of the provisions of the Financial Services
and Markets Act 2000 (“FSMA”) and any rules or regulations made under the FSMA to implement the Insurance Distribution
Directive, where that customer would not qualify as a professional client, as defined in point (8) of Article 2(1) of Regulation
(EU) No 600/2014 as it forms part of domestic law by virtue of the EUWA; or (iii) not a qualified investor as defined in article
2 of Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the EUWA. Consequently, no key information document required
by Regulation (EU) No 1286/2014 as it forms part of domestic law by virtue of the EUWA (the “UK PRIIPs Regulation”) for offering
or selling the shares of Series B Preferred Stock or otherwise making them available to retail investors in the UK has been prepared
and therefore offering or selling the shares of Series B Preferred Stock or otherwise making them available to any retail investor
in the UK may be unlawful under the UK PRIIPs Regulation.

<div align='center'>S-28

LEGAL MATTERS</div>

Certain legal matters will be passed upon for
us by Vinson & Elkins L.L.P., Richmond, Virginia, and, with respect to matters of Maryland law, by Venable LLP, Baltimore, Maryland.
Certain legal matters will be passed upon for the underwriters by Cooley LLP, New York, New York.

<div align='center'>EXPERTS</div>

The financial statements of Global Medical REIT Inc. and the related
financial statement schedule as of December 31, 2024 and 2023, and for each of the three years in the period ended December 31, 2024,
incorporated by reference in this Prospectus by reference to Global Medical REIT Inc.’s